Carl Zeiss Meditec Appoints Global Sales Leader for Ophthalmic Devices
DUBLIN, CA USA / JENA, GERMANY- In August 2016, Carl Zeiss Meditec consolidated its ophthalmic diagnostic and surgical business into a single Strategic Business Unit (SBU) Global Ophthalmic Devices headed by Jim Mazzo. ZEISS announces that the Global Sales organization for the newly consolidated SBU, comprised of Surgical Ophthalmology, Ophthalmic Diagnostics and Refractive Lasers, will be led by Andrew Ihan Chang.
Prior to joining ZEISS, Chang was General Manager and Senior Vice President for Bausch + Lomb Surgical where he led the sales, marketing, operations and business development for the US. Previously at Optimedica Corporation / Abbott Medical Optics, Inc., Chang led the marketing and launch of new laser systems and new indications globally. At ISTA Pharmaceutical / Bausch + Lomb, Chang held various marketing, sales and product development roles and led the market introductions of ophthalmic pharmaceuticals.
For full press release, click HERE.